SNDX-5613

SNDX-5613
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T12943-1mg 1 mg

7 - 10 business days*

67.00€
TGM-T12943-2mg 2 mg

7 - 10 business days*

98.00€
TGM-T12943-5mg 5 mg

7 - 10 business days*

161.00€
TGM-T12943-1mL 1 ml

7 - 10 business days*

228.00€
TGM-T12943-10mg 10 mg

7 - 10 business days*

287.00€
TGM-T12943-25mg 25 mg

7 - 10 business days*

569.00€
TGM-T12943-50mg 50 mg

7 - 10 business days*

819.00€
TGM-T12943-100mg 100 mg

7 - 10 business days*

1,130.00€
 
Description: SNDX-5613 is a potent and specific inhibitor of Menin-MLL(Ki of 0.149 nM and a cell... more
Product information "SNDX-5613"
Description: SNDX-5613 is a potent and specific inhibitor of Menin-MLL(Ki of 0.149 nM and a cell based IC50 of 10-20 nM). SNDX-5613 can be used for the research of MLL-rearranged (MLL-r) acute leukemias. Target: Epigenetic Reader Domain, Histone Methyltransferase. Smiles: CCN(C(C)C)C(=O)c1cc(F)ccc1Oc1cncnc1N1CC2(C1)CCN(C[C@H]1CC[C@@H](CC1)NS(=O)(=O)CC)CC2. References: A drug, SNDX-5613, to treat acute leukemia with a KMT2A translocation or an NPM1 mutation that has come back (relapsed) or has not gotten better with treatment (refractory).
Supplier: TargetMol
Supplier-Nr: T12943

Properties

Application: Targets menin (MEN1, MNN1)
MW: 630.82 D
Formula: C32H47FN6O4S

Database Information

CAS : 2169919-21-3| Matching products
KEGG ID : K14970 | Matching products
Protein Atlas Nr. : Gene Regulation

Handling & Safety

Storage: +4°C
Shipping: +4°C (International: +4°C)
Signal Word: Warning
GHS Hazard Pictograms:
H Phrases: H302, H410
P Phrases: P264, P270, P273, P330, P391, P301+P310, P501
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "SNDX-5613"
Write a review
or to review a product.
Viewed